Novo Nordisk announces Maziar Mike Doustdar as new CEO

Novo Nordisk announces Maziar Mike Doustdar as new CEO

Novo Nordisk said Tuesday it was tapping Maziar Mike Doustdar, its head of international operations, as its new CEO, amid a broader leadership shakeup across the company. Novo’s current CEO, Lars Fruergaard Jørgensen, announced he was stepping down in May, as the company faced a tumbling share price and growing competition from Eli Lilly in the…

Read More
How Custom DNA on Demand Has Created a Shift From Waiting Weeks to Getting Constructs in Days

How Custom DNA on Demand Has Created a Shift From Waiting Weeks to Getting Constructs in Days

Waiting has never been a friend to discovery as it drags behind every new hypothesis and slows the launch of experiments that could lead to breakthroughs in genetic medicine, synthetic biology, or advanced diagnostics. The turnaround for custom DNA constructs once took weeks, forcing scientists to wait out shipping times, production delays, and backlogs. Each…

Read More
Pharma tariffs set at 15% in European Union trade deal

Pharma tariffs set at 15% in European Union trade deal

WASHINGTON — President Trump’s tariffs on pharmaceuticals coming from the European Union will be set at 15% and will not go into effect until a national security investigation has been completed, according to a White House official familiar with the plans.  Once the Section 232 investigation is finished and its associated tariffs are levied, they…

Read More
The Impact of Alcohol and Substance Use on Depression

The Impact of Alcohol and Substance Use on Depression

While a person might depend on substances to ease depression symptoms, chemical intoxication can actually worsen depressive episodes, intensifying the frequency and severity of negative thoughts and self-destructive actions. A depression and addiction treatment addresses both conditions and stops the progression of disorders and enabling the person to create a healthy, sober lifestyle during recovery…

Read More